Friday 6 November 2026
Export AVNT’s income statement to Excel — free account
Avient Corporation
AVNT Basic Materials Specialty Chemicals
Avient Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 0.61% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +31.8%
- Free cash flow
- +101.7%
- Total debt
- −7.34%
Quarter to September 2026, against a year earlier
45.55
0.23
+0.51%
Follow AVNT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
20.39 | 19.87 | 21.10 | 35.10 |
+8 more quarters Free account |
P/S ratio |
1.08 | 1.02 | 1.01 | 0.88 | |
P/FCF ratio |
15.44 | 17.76 | 16.23 | 14.66 | |
P/Operating CF |
30.58 | 36.13 | (96.48) | 17.03 | |
P/B ratio |
265.53 | 1.38 | 1.38 | 1.20 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.48 | 1.45 | 1.47 | 1.31 | |
EV/EBITDA |
10.03 | 9.57 | 9.91 | 10.97 | |
EV/Operating CF |
14.58 | 16.17 | 15.17 | 14.16 | |
EV/FCF |
21.22 | 25.36 | 23.53 | 21.90 | |
Quick Ratio |
1.10 | 1.21 | 1.17 | 1.12 | |
Current Ratio |
1.71 | 1.90 | 1.77 | 1.66 | |
Net Debt/EBITDA |
0.00 | 9.00 | 10.42 | 16.29 | |
Debt/Assets |
30.73% | 31.24% | 32.37% | 31.92% | |
Debt/Equity |
0.74 | 0.77 | 0.80 | 0.81 | |
Asset Turnover |
0.57 | 0.55 | 0.56 | 0.55 | |
Operating CF/Net income |
2.83 | 1.45 | (0.62) | 9.93 | |
Capex/Depreciation |
(0.53) | (0.46) | (0.40) | (0.90) | |
Interest Coverage |
3.64 | 5.04 | 4.35 | 1.74 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.23% | 21.29% | 20.86% | 24.98% | |
Intangible Assets out of Total Assets |
0.53 | 0.53 | 0.54 | 0.54 | |
Share Based Compensation of Revenue |
0.28% | 0.22% | 0.25% | 0.29% | |
Graham Net Nets |
(0.53) | (0.60) | (0.63) | (0.78) | |
Graham Number |
2.60 | 33.44 | 31.94 | 22.85 | |
Earnings Yield |
4.91% | 5.03% | 4.74% | 2.85% | |
Free Cash Flow Yield |
6.48% | 5.63% | 6.16% | 6.82% | |
Revenue per Share |
9.72 | 10.00 | 9.24 | 8.31 | |
Operating CF per Share |
1.32 | 1.02 | (0.38) | 1.83 | |
Capex per Share |
(0.27) | (0.24) | (0.21) | (0.46) | |
Free Cash Flow per Share |
1.04 | 0.78 | (0.58) | 1.37 | |
Cash per Share |
4.86 | 4.64 | 4.66 | 5.58 | |
Shareholders Equity per Share |
26.94 | 26.72 | 26.37 | 26.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
26.94 | 26.72 | 26.37 | 26.08 | |
Free Cash Flow |
95.60 | 71.50 | (53.50) | 125.40 | |
Working Capital |
628.80 | 726.50 | 620.80 | 554.60 | |
Capital Expenditures |
(25.10) | (22.30) | (19.00) | (42.40) | |
Net Current Asset Value |
(1,965.40) | (2,021.40) | (2,102.90) | (2,238.40) | |
EV/EBIT |
15.35 | 15.37 | 16.16 | 20.99 | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.06 | |
Price to Operating Income |
11.17 | 10.76 | 11.15 | 14.05 | |
| Other line items | |||||
Average Receivables |
502.60 | 538.45 | 501.50 | 417.25 | |
Average Payables |
416.55 | 457.05 | 424.15 | 413.70 | |
Average Inventory |
417.20 | 415.25 | 379.60 | 357.00 | |
Average Assets |
6,000.60 | 6,069.05 | 5,878.00 | 5,918.35 | |
Average Common Equity |
1,201.15 | 2,412.00 | 2,366.20 | 2,357.95 |
Columns are period end dates · fundamentals updated 5 Nov 2026